Literature DB >> 32534456

Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group.

S Rocchi1,2, E Scherer1,2, C Mengoli3, A Alanio4,5,6, F Botterel7,8, M E Bougnoux9,10, S Bretagne4,5,6, M Cogliati11, M Cornu12, F Dalle13,14, C Damiani15,16, J Denis17, S Fuchs18, M Gits-Muselli5,6, F Hagen19,20,21, C Halliday22, R Hare23, X Iriart24,25, C Klaassen26, M Lackner27, M Lengerova28, V Letscher-Bru17, F Morio29,30, C Nourrisson31, W Posch18, B Sendid12, J Springer32, B Willinger33, P L White34, R A Barnes35, M Cruciani36, J P Donnelly37, J Loeffler32, L Millon1,2.   

Abstract

Interlaboratory evaluations of Mucorales qPCR assays were developed to assess the reproducibility and performance of methods currently used. The participants comprised 12 laboratories from French university hospitals (nine of them participating in the Modimucor study) and 11 laboratories participating in the Fungal PCR Initiative. For panel 1, three sera were each spiked with DNA from three different species (Rhizomucor pusillus, Lichtheimia corymbifera, Rhizopus oryzae). For panel 2, six sera with three concentrations of R. pusillus and L. corymbifera (1, 10, and 100 genomes/ml) were prepared. Each panel included a blind negative-control serum. A form was distributed with each panel to collect results and required technical information, including DNA extraction method, sample volume used, DNA elution volume, qPCR method, qPCR template input volume, qPCR total reaction volume, qPCR platform, and qPCR reagents used. For panel 1, assessing 18 different protocols, qualitative results (positive or negative) were correct in 97% of cases (70/72). A very low interlaboratory variability in Cq values (SD = 1.89 cycles) were observed. For panel 2 assessing 26 different protocols, the detection rates were high (77-100%) for 5/6 of spiked serum. There was a significant association between the qPCR platform and performance. However, certain technical steps and optimal combinations of factors may also impact performance. The good reproducibility and performance demonstrated in this study support the use of Mucorales qPCR as part of the diagnostic strategy for mucormycosis.
© The Author(s) 2020. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Entities:  

Keywords:  Mucorales PCR; circulating DNA; interlaboratory assay; standardization

Year:  2020        PMID: 32534456     DOI: 10.1093/mmy/myaa036

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  7 in total

Review 1.  Recent Developments in the Diagnosis of Mucormycosis.

Authors:  Eric Dannaoui
Journal:  J Fungi (Basel)       Date:  2022-04-28

2.  Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC).

Authors:  Sean X Zhang; N Esther Babady; Kimberly E Hanson; Amanda T Harrington; Paige M K Larkin; Sixto M Leal; Paul M Luethy; Isabella W Martin; Preeti Pancholi; Gary W Procop; Stefan Riedel; Seyedmojtaba Seyedmousavi; Kaede V Sullivan; Thomas J Walsh; Shawn R Lockhart
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

Review 3.  Recent Advances and Novel Approaches in Laboratory-Based Diagnostic Mycology.

Authors:  Lewis P White; Jessica S Price
Journal:  J Fungi (Basel)       Date:  2021-01-11

4.  Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?

Authors:  Sarah Dellière; Emmanuel Dudoignon; Sébastian Voicu; Magalie Collet; Sofiane Fodil; Benoit Plaud; Benjamin Chousterman; Stéphane Bretagne; Elie Azoulay; Alexandre Mebazaa; François Dépret; Bruno Mégarbane; Alexandre Alanio
Journal:  J Clin Microbiol       Date:  2022-01-05       Impact factor: 5.948

Review 5.  Recent Advances and Future Directions in the Understanding of Mucormycosis.

Authors:  Victoriano Garre
Journal:  Front Cell Infect Microbiol       Date:  2022-02-24       Impact factor: 5.293

6.  Analytical Performance of the Commercial MucorGenius® Assay as Compared to an In-House qPCR Assay to Detect Mucorales DNA in Serum Specimens.

Authors:  Théo Ghelfenstein-Ferreira; Laura Verdurme; Alexandre Alanio
Journal:  J Fungi (Basel)       Date:  2022-07-27

7.  Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement.

Authors:  Jeffrey D Jenks; Jean-Pierre Gangneux; Ilan S Schwartz; Ana Alastruey-Izquierdo; Katrien Lagrou; George R Thompson Iii; Cornelia Lass-Flörl; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2020-10-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.